Dear Attendee, Eric Fry here with a friendly reminder that your special report is on hold… Click here and learn how to claim The Next $1 Trillion AI Stock: How to Make 40 Years of Nvidia Gains in Months. Like I showed you earlier this week… We don’t have much time to act. A private company called Insilico Medicine has used AI to develop a drug to treat a deadly lung disease called IPF. And last year, it advanced that drug to Phase 2 clinical trials. Since they’re using AI in every step of the process... Things are moving much faster than average. Insilico moved from design to Phase 1 in about half the time it would take with traditional drug discovery. It started this Phase 2 human trial in June of last year. And it said it would announce the results of that trial sometime this year. Since Insilico has been moving so fast… I believe this announcement is imminent. Once they announce positive results of this human trial… It could send shares of this company I’m recommending skyrocketing higher. Now, since you haven’t claimed your special report yet… Maybe you still have some questions. So I want to answer a few bonus questions we didn’t have time to cover during our event’s Q&A. QUESTION: “I understand this company is using AI to revolutionize healthcare. But isn't it risky to invest in these tiny biotech firms?” To be clear… The company I’m recommending is a well-established firm that already scored nine FDA approvals last year alone. It has developed some of the most successful drugs in history… Including one drug that generated more than $100 billion in sales alone. This company has already entered into several partnerships with other companies that own AI platforms. And already has more than 100 new drugs in their pipeline… Targeting several diseases, including cancer. This is NOT a risky, tiny biotech firm that could go bankrupt at any moment. Having said that… With these types of big, relatively safer companies… It could take years for you to see big gains if you’re just buying shares. Which is why I’m recommending LEAPs… or long-term options. Click here to get all the details of this trade before it’s too late. QUESTION: “What if I’ve never traded options before?” That’s not a problem at all. My team and I created an options course with all the basics. And the moment you click here and join The Speculator… This course will be yours completely free of charge. It’s a video tutorial called Make Your First LEAPS Trade in Minutes. I’ll walk you step by step on how to execute these trade recommendations. I’m confident that once you watch this short video… You’ll find that trading these options can be as easy as buying stocks. QUESTION: “What if I join The Speculator, but change my mind later?” You’ll be protected by my Satisfaction Guarantee AND a performance promise. Here’s how it works… First, you’ll have 90 days to try this service. If for any reason you’re not happy with The Speculator… Just contact our member services within the first 90 days… And you’ll get a full credit refund good for any of the two dozen different products my publisher offers. That means this credit covers the full cost of your subscription. And you can keep everything you see on this offer page… Including the special reports The Next $1 Trillion AI Stock… My Watchlist With my Top Five AI Biotech Stocks… And The Top Five 10X Trades for the AI Wars of 2024. That's my satisfaction guarantee. And that’s not all… You’re also protected by my performance promise... If my AI accelerator strategy tracked in our model portfolio doesn’t show you at least 10X more gains than the S&P 500 over the next 12 months… You’ll get another year of The Speculator, 100% free. That’s another $4,000 value, at no extra charge. So go ahead and click here to get started. QUESTION: Can I watch the replay of the event? Yes. Some of the attendees couldn’t watch the entire interview and they ended up missing what could be the #1 AI trade of 2024. So I had my team post the official replay of The Next $1 Trillion AI Stock online for you. Click here to stream it. Just keep in mind my publisher could remove this from the web at any moment now. If you try to come back tomorrow, this page could be gone. QUESTION: Can I still get the name of your free recommendation? Yes. Click here to watch the replay and write that down… Because I believe this play could double your money in the coming months and years. Regards, 
Eric Fry
Senior Macro-Investment Analyst, InvestorPlace | 
Post a Comment
Post a Comment